ability
bacteria
activate
terminal
complement
components
serum
patients
cystic
fibrosis
terminal
complement
components
c
c
contribute
host
defense
infection
study
performed
determine
defective
activation
c
c
bacteria
contributes
pathogenesis
recurrent
pulmonary
infections
cystic
fibrosis
bacteria
incubated
serum
patients
cystic
fibrosis
minutes
consumption
available
c
sera
control
patients
two
patients
chronic
severe
bronchiectasis
based
results
present
study
unlikely
defective
activation
c
c
contributes
pathogenesis
increased
susceptibility
pulmonary
infections
patients
